Global Dermatologicals Market Statistics, Development and Growth 2021
The lockdown measures introduced by the government in a bid to stop the spread of COVID-19 meant that Peruvians were forced to remain at home from March to May 2020. This therefore limited demand for many dermatological products, with the spread of fungal infections limited and less people exposed to UV rays and other environmental factors which could damage their skin. As a result, fewer people were encouraged to seek out products for the prevention and relief of these conditions.
Euromonitor International's Dermatologicals in Peru report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
COVID-19 lockdown reduces demand for
dermatological products in 2020 as consumers stay at home
ABL Pharma Peru continues to lead
dermatologicals in 2020, while Farmindustria and Genomma Lab also perform well
Healthy growth recorded by generics in topical
antifungals in 2020
RECOVERY AND OPPORTUNITIES
Dermatological products with natural
ingredients expected to see increase in popularity into forecast period
High temperatures see proliferation of insects
and higher levels of fungal infections
Despite players’ investments in advertising,
pharmacists’ advice at point of sale can still be key
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss
Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment